Abstract
Background: Transitional Age Youth (TAY), the period between 15-25 years old, is now recognized as a unique developmental stage and a highly vulnerable time period for the onset of Serious Mental Illness (SMI).
Objective: The study aimed to inform readers about TAY with SMI to improve recognition of their developmental needs and improve patient care.
Methods: The authors describe their work with TAY experiencing SMI on inpatient psychiatric units by citing case examples that illustrate individual treatment issues, the level of family involvement in care, and social/systems based practice.
Results: TAY patients with SMI are more likely to adhere to ongoing psychiatric care when their developmental needs are addressed while in an acute inpatient setting.
Conclusion: Focusing on mental health needs of TAY while applying a developmental perspective can improve patient care and compliance to treatment.
Keywords: Transitional Age Youth (TAY), Serious Mental Illness (SMI), developmental perspective, biopsychosocial formulation, treatment issues, clinical case.
Adolescent Psychiatry
Title:Transitional Age Youth with Serious Mental Illness: High Acuity Patients Requiring Developmentally Informed Care in the Inpatient Hospital Setting
Volume: 8 Issue: 3
Author(s): Timothy Van Deusen*, Cynthia Wilson, Hyun Jung Kim, Zheala Qayyum, Hun Millard and Susan Parke
Affiliation:
- Department of Psychiatry, Yale School of Medicine, West Haven Mental Health Clinic, 270 Center St., West Haven, CT,United States
Keywords: Transitional Age Youth (TAY), Serious Mental Illness (SMI), developmental perspective, biopsychosocial formulation, treatment issues, clinical case.
Abstract: Background: Transitional Age Youth (TAY), the period between 15-25 years old, is now recognized as a unique developmental stage and a highly vulnerable time period for the onset of Serious Mental Illness (SMI).
Objective: The study aimed to inform readers about TAY with SMI to improve recognition of their developmental needs and improve patient care.
Methods: The authors describe their work with TAY experiencing SMI on inpatient psychiatric units by citing case examples that illustrate individual treatment issues, the level of family involvement in care, and social/systems based practice.
Results: TAY patients with SMI are more likely to adhere to ongoing psychiatric care when their developmental needs are addressed while in an acute inpatient setting.
Conclusion: Focusing on mental health needs of TAY while applying a developmental perspective can improve patient care and compliance to treatment.
Export Options
About this article
Cite this article as:
Van Deusen Timothy*, Wilson Cynthia, Kim Jung Hyun, Qayyum Zheala, Millard Hun and Parke Susan, Transitional Age Youth with Serious Mental Illness: High Acuity Patients Requiring Developmentally Informed Care in the Inpatient Hospital Setting, Adolescent Psychiatry 2018; 8 (3) . https://dx.doi.org/10.2174/2210676608666180820153318
DOI https://dx.doi.org/10.2174/2210676608666180820153318 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nogo Receptor Interacts with Brain APP and Aβ to Reduce Pathologic Changes in Alzheimers Transgenic Mice
Current Alzheimer Research Exploring Structural and Physicochemical Profiles of Potential GSK-3β Inhibitors Using Structure- and Ligand-Based Modeling Studies
Combinatorial Chemistry & High Throughput Screening Methods for Detection of Speech Impairment Using Mobile Devices
Recent Patents on Signal Processing (Discontinued) Recent Gains in Clinical Multiple Sclerosis Research
CNS & Neurological Disorders - Drug Targets Polypharmacology in a Single Drug: Multitarget Drugs
Current Medicinal Chemistry The TLR9 Antagonist iCpG-ODN at Different Dosages Inhibits Cerebral Ischemia/Reperfusion Injury in Mice
CNS & Neurological Disorders - Drug Targets Cationicity and Hydrophobicity Enhance the Cytotoxic Potency of Phoratoxin C Anticancer Peptide Analogues against Triple Negative Breast Cancer Cells
Current Bioactive Compounds On the Relationship Between the Light/Dark Cycle, Melatonin and Oxidative Stress
Current Pharmaceutical Design Salvinorin A and Related Compounds as Therapeutic Drugs for Psychostimulant-Related Disorders
Current Drug Abuse Reviews Late-life Depression and Alzheimer Disease: A Potential Synergy of the Underlying Mechanisms
Current Medicinal Chemistry The Role of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease Diagnosis. Where are we Now?
Recent Patents on CNS Drug Discovery (Discontinued) Preface:
CNS & Neurological Disorders - Drug Targets Recent Pharmacoproteomics Studies of Warfarin in the Asia-Pacific: A New Strategy for Personalized Medicine?
Current Pharmacogenomics and Personalized Medicine Editorial [Hot Topic: Perspectives in Integrin Blocking (Executive Editor: C. Marcinkiewicz)]
Current Pharmaceutical Design Towards Second Generation Hypericin Based Photosensitizers for Photodynamic Therapy
Current Organic Chemistry Genomic and Pharmacogenomic Biomarkers of Parkinson’s Disease
Current Drug Metabolism Vortioxetine Treatment for Anxiety Disorder: A Meta-Analysis Study
Current Drug Targets Recent Advances in the Synthesis and Applications of Reduced Amide Pseudopeptides
Current Medicinal Chemistry Metabotropic GABAB Receptors New Challenges in Drug Design
Current Medicinal Chemistry - Central Nervous System Agents Potential Therapeutic Role of Carnitine and Acetylcarnitine in Neurological Disorders
Current Pharmaceutical Design